[1]
Papp, K., Szepietowski, J.C., Kircik, L., Toth, D., Kuligowski, M.E., Venturanza, M.E., Sun, K. and Simpson, E.L. 2020. Efficacy and Safety of Ruxolitinib Cream for the Treatment of Atopic Dermatitis: Results From Two Phase 3, Randomized, Double-Blind Studies. SKIN The Journal of Cutaneous Medicine. 4, 6 (Oct. 2020), s95. DOI:https://doi.org/10.25251/skin.4.supp.95.